PHASE III STUDY COMPARING STANDARD DOSE-DENSE EPIRUBICIN-CONTAINING CHEMOTHERAPY IN EARLY BREAST CANCER: PROGNOSTIC AND PREDICTIVE ROLE OF HER-2


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles